Physicians Realty Trust (NYSE:DOC) went down by -0.94% from its latest closing price compared to the recent 1-year high of $19.30. The company’s stock price has collected -1.55% of loss in the last five trading sessions.
Is It Worth Investing in Physicians Realty Trust (NYSE :DOC) Right Now?
Physicians Realty Trust (NYSE:DOC) scored a price-to-earnings ratio above its average ratio, recording 44.84 x from its present earnings ratio. Plus, the 36-month beta value for DOC is at 0.77. Opinions of the stock are interesting as 4 analysts out of 17 who provided ratings for Physicians Realty Trust declared the stock was a “buy,” while 1 rated the stock as “overweight,” 11 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $19.00, which is $3.24 above the current price. DOC currently public float of 224.25M and currently shorts hold a 4.75% ratio of that float. Today, the average trading volume of DOC was 1.76M shares.
DOC’s Market Performance
DOC stocks went down by -1.55% for the week, with a monthly drop of -10.06% and a quarterly performance of -7.64%, while its annual performance rate touched -13.50%. The volatility ratio for the week stands at 2.52% while the volatility levels for the past 30 days are set at 2.11% for Physicians Realty Trust. The simple moving average for the period of the last 20 days is -5.53% for DOC stocks with a simple moving average of -9.79% for the last 200 days.
Analysts’ Opinion of DOC
Many brokerage firms have already submitted their reports for DOC stocks, with Colliers Securities repeating the rating for DOC by listing it as a “Neutral.” The predicted price for DOC in the upcoming period, according to Colliers Securities is $19 based on the research report published on August 05th of the current year 2022.
CapitalOne, on the other hand, stated in their research note that they expect to see DOC reach a price target of $20. The rating they have provided for DOC stocks is “Equal Weight” according to the report published on June 03rd, 2022.
BofA Securities gave a rating of “Underperform” to DOC, setting the target price at $18 in the report published on May 19th of the current year.
DOC Trading at -7.61% from the 50-Day Moving Average
After a stumble in the market that brought DOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.98% of loss for the given period.
Volatility was left at 2.11%, however, over the last 30 days, the volatility rate increased by 2.52%, as shares sank -8.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.64% lower at present.
During the last 5 trading sessions, DOC fell by -1.55%, which changed the moving average for the period of 200-days by -12.54% in comparison to the 20-day moving average, which settled at $16.68. In addition, Physicians Realty Trust saw -15.93% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at DOC starting from Thomas John T, who sale 10,000 shares at the price of $17.81 back on Aug 19. After this action, Thomas John T now owns 459,801 shares of Physicians Realty Trust, valued at $178,100 using the latest closing price.
Thomas John T, the President and CEO of Physicians Realty Trust, sale 10,000 shares at $18.08 during a trade that took place back on Aug 18, which means that Thomas John T is holding 469,801 shares at $180,800 based on the most recent closing price.
Stock Fundamentals for DOC
Current profitability levels for the company are sitting at:
- +27.24 for the present operating margin
- +35.49 for the gross margin
The net margin for Physicians Realty Trust stands at +18.35. Equity return is now at value 2.80, with 1.60 for asset returns.